Shareholder Tools
Investors
Corporate Governance
The Board of Directors of Trius Therapeutics (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.
| Document | View | ||
|---|---|---|---|
| Audit Committee |  |
6.8 KB
|
|
| Compensation Committee | |
6.9 KB
|
|
| Nominating and Corporate Governance Committee | |
6.2 KB
|
|
Code of Business Conduct and Ethics and Open Door Policy for Reporting Complaints Regarding Accounting and Auditing Matters
The Company is committed to maintaining the highest standards of business conduct and ethics. Our Code of Business Conduct and Ethics reflects the business practices and principles of behavior that support this commitment.
In addition, the Company is committed to providing a workplace conducive to open discussion of our business practices and is committed to complying with the laws and regulations to which we are subject. Accordingly, the Company has developed its Open Door Policy for Reporting Complaints Regarding Accounting and Auditing Matters. This policy is a supplement to the Code of Business Conduct and Ethics and should be read in conjunction with it.
Code of Business ConductOpen Door Policy